Literature DB >> 1649506

Human rhinovirus mutants resistant to low pH.

T Skern1, H Torgersen, H Auer, E Kuechler, D Blaas.   

Abstract

Mutants of human rhinovirus serotype 14 (HRV14) with increased resistance to treatment at low pH were obtained by repeated cycles of exposure to pH 4.5 and propagation in HeLa cells. Whereas wild-type virus lost more than 5 logs of infectivity upon incubation at pH 4.3, the three isolates examined were essentially unaffected. Conformational change of the viral capsid upon exposure to low pH was assessed as an increase of hydrophobicity by partition between an aqueous phase and a Triton X-114 phase; the mutants required exposure to a much lower pH to accumulate in the Triton phase than wild-type HRV14. The sequence of the capsid region was determined for three isolates; two isolates were found to have the changes Thr17 to lie in VP2 and Asn 100 to lie in VP1. The third isolate also had the change Thr17 to Ile in VP2; however, in VP1, Asp101 was replaced by Glu. Separate introduction of the mutations into full length cDNA clones of the wild-type sequence of HRV14 showed that only the changes in VP1 were necessary for the increased stability at pH 4.5. The implications of the mutations for the three-dimensional structure of the viral capsid are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649506     DOI: 10.1016/0042-6822(91)91006-3

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  A coding RNA sequence acts as a replication signal in cardioviruses.

Authors:  P E Lobert; N Escriou; J Ruelle; T Michiels
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Acid-induced structural changes in human rhinovirus 14: possible role in uncoating.

Authors:  V L Giranda; B A Heinz; M A Oliveira; I Minor; K H Kim; P R Kolatkar; M G Rossmann; R R Rueckert
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

3.  The concentration of Ca2+ that solubilizes outer capsid proteins from rotavirus particles is dependent on the strain.

Authors:  M C Ruiz; A Charpilienne; F Liprandi; R Gajardo; F Michelangeli; J Cohen
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Equine Rhinitis A Virus Mutants with Altered Acid Resistance Unveil a Key Role of VP3 and Intrasubunit Interactions in the Control of the pH Stability of the Aphthovirus Capsid.

Authors:  Flavia Caridi; Rodrigo Cañas-Arranz; Angela Vázquez-Calvo; Francisco Sobrino; Miguel A Martín-Acebes
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

5.  Conformational maturation and post-ER multisubunit assembly of gap junction proteins.

Authors:  Judy K Vanslyke; Christian C Naus; Linda S Musil
Journal:  Mol Biol Cell       Date:  2009-03-18       Impact factor: 4.138

6.  Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids.

Authors:  S Curry; C C Abrams; E Fry; J C Crowther; G J Belsham; D I Stuart; A M King
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

7.  Construction of a recombinant rhinovirus accommodating fluorescent marker expression.

Authors:  Mingyuan Han; Charu Rajput; Joanna L Hinde; Qian Wu; Jing Lei; Tomoko Ishikawa; J Kelley Bentley; Marc B Hershenson
Journal:  Influenza Other Respir Viruses       Date:  2018-09-06       Impact factor: 4.380

8.  RIPK1 Is Cleaved by 3C Protease of Rhinovirus A and B Strains and Minor and Major Groups.

Authors:  Sarah N Croft; Erin J Walker; Reena Ghildyal
Journal:  Viruses       Date:  2021-11-30       Impact factor: 5.048

9.  Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating.

Authors:  Luca Murer; Anthony Petkidis; Thomas Vallet; Marco Vignuzzi; Urs F Greber
Journal:  J Virol       Date:  2021-10-27       Impact factor: 5.103

10.  Productive entry pathways of human rhinoviruses.

Authors:  Renate Fuchs; Dieter Blaas
Journal:  Adv Virol       Date:  2012-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.